Funding for this research was provided by:
Guy's and St Thomas' Charity (MAJ130202)
Received: 13 December 2018
Accepted: 20 September 2019
First Online: 22 October 2019
Change Date: 12 August 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via the original article.
Ethics approval and consent to participate
: Ethical approval was granted by the Camberwell St Giles Research Ethics Committee, REC reference number 15/LO/0058<b>.</b> Written informed consent will be obtained from all participants.
: No details, images or videos relating to an individual person are intended to be published.
: MH reported grants from Innovative Medicines Initiative and European Federation of Pharmaceutical Industries and Associations, outside the submitted work. In addition, TC and RMM declared the following; Organisational financial interests: TC received ad hoc payments for conducting workshops on evidence-based treatments for persistent physical symptoms. TC has received grants from NIHR programme grants, HTA, RfPB, Guy’s and St Thomas Charity, King’s Challenge Fund, Muscular Dystrophy, Multiple Sclerosis Society. KCL received payment from Taylor and Francis for editorial role. RMM currently receives grant funding from NIHR programme grants, Breast Cancer Now, Crohn’s and Colitis UK, and National MS Society. In the previous 36 months, RMM received funding from MS society UK and NIHR HTA. In 2019, payments from Taylor and Francis to KCL for RMM’s role as Editor of Health Psychology Review. Payments for adhoc lectures and workshops on Long term conditions. Personal financial interests: TC is the author of several self-help books on chronic fatigue and received royalties in the past. TC received expenses and ad hoc payment for role as external examiner NUI Galway and Waterford Institute of Technology. TC received expenses for keynote speeches at UK Society for Behavioural Medicine, BABCP Conferences (travel and accommodation). TC received ad hoc payments for conducting workshops on evidence-based treatments for persistent physical symptoms. RMM received payments for her role as National Advisor to NHS England for Increasing Access to Psychological Therapies (IAPT) for People with Long Term Conditions from 2011 to 2016. RMM received ad hoc payments for workshop training in IBS in 2017 and 2018 and this will continue in 2019. RMM receives ad hoc consultancy payments from Mahana therapeutics and this is likely to continue in 2019. RMM has stock options in Mahana therapeutics. RMM received travel expenses for keynote speech to Internal Society of Behavioural Medicine. In 2019 RMM will be a keynote speaker for Association for Researchers in Psychology and Health (the Netherlands), European Health Psychology Society Annual Conference (Croatia), and the 9th World Congress of Behavioural and Cognitive Therapies (Germany). Travel and accommodation expenses will be reimbursed. All other authors declare no conflicts of interest. The authors acknowledge the financial support of the Department of Health via the National Institute for Health Research (NIHR) Specialist Biomedical Research Centre for Mental Health award to the South London and Maudsley NHS Foundation Trust (SLaM) and the Institute of Psychiatry at King’s College London. The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.